CLINICAL_TRIALS
trial_result
· 2008-04-10
Clinical Trial Update: Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance [Phase 4]
Summary
Phase 4 clinical trial update reports the efficacy and tolerability of Arsucam (artesunate plus amodiaquine) for malaria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Malaria | Phase 4 | Status: COMPLETED